Stella Grosser

1.4k total citations
35 papers, 945 citations indexed

About

Stella Grosser is a scholar working on Statistics and Probability, Management Science and Operations Research and Immunology. According to data from OpenAlex, Stella Grosser has authored 35 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Statistics and Probability, 8 papers in Management Science and Operations Research and 7 papers in Immunology. Recurrent topics in Stella Grosser's work include Statistical Methods in Clinical Trials (14 papers), Optimal Experimental Design Methods (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Stella Grosser is often cited by papers focused on Statistical Methods in Clinical Trials (14 papers), Optimal Experimental Design Methods (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Stella Grosser collaborates with scholars based in United States, France and Australia. Stella Grosser's co-authors include Alice S. Whittemore, James B. Kampert, Samuel C. Ballon, Michael Hendrickson, Victoria Hendrick, Lori L. Altshuler, Ralph S. Paffenbarger, Dexter L. Jung, Janet C. Mohle‐Boetani and Mary Malec and has published in prestigious journals such as Journal of the American Statistical Association, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Stella Grosser

33 papers receiving 895 citations

Peers

Stella Grosser

PHEOH

ONCOL

EPIDE

Peter Lindgren Sweden

Georgios Iatrakis Greece

Claudia Massarotti Italy

Jenna Haverfield Canada

Heather Shapiro Canada

Sarah Finlayson Canada

Erica Silvestris Italy

Giuseppe Pelusi Italy

Åsa Edvinsson Sweden

S.J. Steele United States

Peter Lindgren Sweden

Stella Grosser

216 ×0.7

283 ×1.1

PHEOH

119 ×0.6

ONCOL

254 ×1.6

137 ×1.1

EPIDE

Citations per year, relative to Stella Grosser Stella Grosser (= 1×) peers Peter Lindgren

Countries citing papers authored by Stella Grosser

Since Specialization

Citations

This map shows the geographic impact of Stella Grosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Grosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Grosser more than expected).

Fields of papers citing papers by Stella Grosser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Grosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Grosser. The network helps show where Stella Grosser may publish in the future.

Co-authorship network of co-authors of Stella Grosser

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Grosser. A scholar is included among the top collaborators of Stella Grosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Grosser. Stella Grosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schuirmann, Donald J., Fairouz Makhlouf, Wenlei Jiang, et al.. (2025). A Proposal for Alternative FDA Bioequivalence Criteria for Narrow Therapeutic Index Drug Products to Support Future Harmonization. Pharmaceutical Research. 42(10). 1677–1690.

Fang, Lanyan, Kairui Feng, Liang Zhao, et al.. (2024). Model‐based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging?. Statistics in Medicine. 43(18). 3403–3416. 2 indexed citations

Kim, Jessica, et al.. (2023). Adaptive designs for IVPT data with mixed scaled average bioequivalence. Pharmaceutical Statistics. 22(6). 1116–1134. 2 indexed citations

Tardivon, Coralie, Kairui Feng, Wanjie Sun, et al.. (2023). Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies. CPT Pharmacometrics & Systems Pharmacology. 12(7). 904–915. 3 indexed citations

Herndon, Thomas M., Cristina Ausín, Sarah J. Schrieber, et al.. (2023). Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis. PLoS ONE. 18(10). e0292231–e0292231. 25 indexed citations

Sharan, Satish, Sungwoo Choi, Yuan Zou, et al.. (2022). Application of Modeling and Simulation to Identify a Shortened Study Duration and Novel Bioequivalence Metric for a Long-Acting Intrauterine System. The AAPS Journal. 24(3). 63–63. 3 indexed citations

Bertrand, Julie, Thu Thuy Nguyen, Satish Sharan, et al.. (2020). New Model–Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling. The AAPS Journal. 22(6). 141–141. 10 indexed citations

Li, Zili, et al.. (2018). Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics. Therapeutic Innovation & Regulatory Science. 53(5). 696–700. 3 indexed citations

Grosser, Stella, et al.. (2015). Determining Equivalence for Generic Locally Acting Drug Products. Statistics in Biopharmaceutical Research. 7(4). 337–345. 6 indexed citations

10.

Wiley, Dorothy J., Stella Grosser, Karen Qi, et al.. (2002). Validity of Self‐Reporting of Episodes of External Genital Warts. Clinical Infectious Diseases. 35(1). 39–45. 21 indexed citations

11.

Wohl, Amy Rock, et al.. (2001). Comparison of AIDS Progression and Survival in Persons with Pulmonary versus Extrapulmonary Tuberculosis in Los Angeles. AIDS Patient Care and STDs. 15(9). 463–471. 8 indexed citations

12.

Hogeboom, Charissa J., Stella Grosser, Katherine A. Guthrie, et al.. (2001). Stature loss following treatment for Wilms tumor. Medical and Pediatric Oncology. 36(2). 295–304. 41 indexed citations

13.

Hendrick, Victoria, et al.. (2000). Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment. Depression and Anxiety. 11(2). 66–72. 147 indexed citations

14.

Salazar-Gonzalez, Jesus F., Otoniel Martı́nez-Maza, P Nishanian, et al.. (1998). Increased Immune Activation Precedes the Inflection Point of CD4 T Cells and the Increased Serum Virus Load in Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 178(2). 423–430. 41 indexed citations

15.

Noble, Ernest P., Terry Ritchie, Bruce R. Lawford, et al.. (1998). D2 dopamine receptor and GABAA receptor β3 subunit genes and alcoholism. Psychiatry Research. 81(2). 133–147. 62 indexed citations

16.

Goddard, Katrina A.B., Gail P. Jarvik, Jinko Graham, et al.. (1995). Analysis of quantitative risk factors for a common oligogenic disease. Genetic Epidemiology. 12(6). 759–764. 7 indexed citations

17.

Gong, Gail, Alice S. Whittemore, & Stella Grosser. (1990). Censored Survival Data with Misclassified Covariates: A Case Study of Breast-Cancer Mortality. Journal of the American Statistical Association. 85(409). 20–28. 15 indexed citations

18.

Whittemore, Alice S., Ralph S. Paffenbarger, Stella Grosser, et al.. (1988). PERSONAL AND ENVIRONMENTAL CHARACTERISTICS RELATED TO EPITHELIAL OVARIAN CANCER. American Journal of Epidemiology. 128(6). 1216–1227. 98 indexed citations

19.

Grosser, Stella, et al.. (1988). Body size, reproductive factors, and breast cancer survival. Preventive Medicine. 17(5). 634–642. 84 indexed citations

20.

Whittemore, Alice S., Ralph S. Paffenbarger, James B. Kampert, et al.. (1988). PERSONAL AND ENVIRONMENTAL CHARACTERISTICS RELATED TO EPITHELIAL OVARIAN CANCER. American Journal of Epidemiology. 128(6). 1228–1240. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact